Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02220790 · ClinicalTrials.gov registry record
BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric Candidemia
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 515
- Enrollment target
NCT02220790 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 515 participants.
The verdict
NCT02220790 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 515 participants
- Enrollment target
Study Summary
The purpose of the study is to 1) define the operating characteristics of fungal biomarker assays in pediatric patients at high-risk for developing invasive candidiasis, 2) determine the change in fungal biomarker assay results in children who develop invasive candidiasis, and 3) create a biobank of blood samples from pediatric patients at high-risk for invasive candidiasis and those with invasive candidiasis for future testing of fungal biomarker assays and development of new fungal biomarker assays. The study will assemble a prospective cohort of pediatric patients at high-risk for developing invasive candidiasis. Blood samples for biomarker testing will be obtained at the time a patient has a clinical indication for blood culture attainment. Additional blood sampling will be performed on the sub-set of patients that are found to have invasive candidiasis. The sensitivity, specificity, PPV, and NPV of biomarker assays will be determined for each biomarker assay. No PHI will be stored in the database and limits on blood draws (3 ml/kg in an 8 week period) will be adhered to.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 515 participants |
| Start Date | 2015-01 |
| Est. Completion | 2020-10-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02220790
The ClinicalTrials.gov registry entry for NCT02220790 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 515 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02220790 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02220790 about?
NCT02220790 is a clinical study titled "BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric Candidemia". The purpose of the study is to 1) define the operating characteristics of fungal biomarker assays in pediatric patients at high-risk for developing invasive candidiasis, 2) determine the change in fungal biomarker assay results in children who develop invasive candidiasis, and 3) create a biobank of...
What is the current status of trial NCT02220790?
This trial is currently completed. The enrollment target is 515 participants. The study started on 2015-01. Estimated completion is 2020-10-08.
Who is sponsoring clinical trial NCT02220790?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.